Josef Endl
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Co-authors
- Werner Scheuer (2 shared papers)Helmut Burtscher (1 shared paper)Thomas Friess (1 shared paper)Birgit Bossenmaier (1 shared paper)Max Hasmann (1 shared paper)Peter Van Endert (2 shared papers)Dolores J. Schendel (3 shared papers)Thomas Eiermann (2 shared papers)
- Journals
- Diabetes (3 papers)Clinical & Experimental Immunology (2 papers)Diabetologia (2 papers)The Journal of Immunology (2 papers)Journal of Neurology Neurosurgery & Psychiatry (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Josef Endl
20 papers receiving 949 citations
Josef Endl's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 394
- Radiology, Nuclear Medicine and Imaging 282
- Genetics 345
- Immunology 227
- Endocrinology, Diabetes and Metabolism 155
Countries citing papers authored by Josef Endl
This map shows the geographic impact of Josef Endl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Endl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Endl more than expected).
Fields of papers citing papers by Josef Endl
This network shows the impact of papers produced by Josef Endl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Endl. The network helps show where Josef Endl may publish in the future.
Co-authors
The 25 scholars most cited alongside Josef Endl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models Hit paper breakdown → | 2009 | 466 |
| 2 | 1997 | 117 | |
| 3 | 1992 | 74 | |
| 4 | 2001 | 64 | |
| 5 | 2014 | 49 | |
| 6 | 2006 | 42 | |
| 7 | 2004 | 40 | |
| 8 | 2003 | 27 | |
| 9 | 2000 | 26 | |
| 10 | 1998 | 20 | |
| 11 | 1993 | 16 | |
| 12 | 2020 | 12 | |
| 13 | 2003 | 7 | |
| 14 | 1997 | 7 | |
| 15 | 2001 | 5 | |
| 16 | 2007 | 2 | |
| 17 | Quantitative analysis of CD6, CD4 and CD8 cell surface molecules compared to the absolute numbers of CD6+, CD4+ and CD8+ T-cells in peripheral blood in patients with HIV-infection. | 1991 | 2 |
| 18 | 1987 | 1 | |
| 19 | 2000 | 1 | |
| 20 | 2006 | 1 |
About Josef Endl
Josef Endl is a scholar working on Genetics, Surgery, Immunology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 979 indexed citations. Recurring topics across this work include Diabetes and associated disorders (13 papers), Pancreatic function and diabetes (9 papers), Diabetes Management and Research (5 papers), Immune Cell Function and Interaction (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), T-cell and B-cell Immunology (2 papers), Protein Tyrosine Phosphatases (2 papers) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Oncology (394 citations), Radiology, Nuclear Medicine and Imaging (282 citations), Genetics (345 citations), Immunology (227 citations) and Endocrinology, Diabetes and Metabolism (155 citations). Josef Endl has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Werner Scheuer, Helmut Burtscher, Thomas Friess, Birgit Bossenmaier, Max Hasmann, Peter Van Endert, Dolores J. Schendel, Thomas Eiermann, Timothy Tree and Bart O. Roep. Their work appears in journals such as Diabetes, Clinical & Experimental Immunology, Diabetologia, The Journal of Immunology and Journal of Neurology Neurosurgery & Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.